FMO5 and Alzheimer disease: Interestingly, it has been demonstrated that in brains of AD patients there is an increase in the expression of NADPH oxidase proteins [26] and that AD model mice lacking gp91phox do not develop oxidative stress, cerebrovascular dysfunction, or behavioral deficits [27].